A descriptive study of potential sight threatening event and severe visual loss following exposure to XALKORI (crizotinib)

First published 29/03/2016

Last updated 23/04/2024

EU PAS number:

EUPAS12963

Study

Finalised

Documents

Study protocol

Initial protocol

A8081062_FINAL_PROTOCOL_CLEAN_16MAR 2016_register

English (1.98 MB - PDF)View document

Updated protocol

A8081062_Protocol_Amendment_1 28 April 2017_EU PAS

First published: 22/02/2024

English (4.04 MB - PDF)View document

Study results

a8081062-report-body

English (5.05 MB - PDF)View document

Study report

a8081062-abstract

English (1.8 MB - PDF)View document

A8081062-first-interim-report

English (1.54 MB - PDF)View document

Other information

Study, other information

A8081062-first-interim-report.pdf

English (1.54 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs